Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
Cyclooxygenase-2 and atherosclerosis
MacRae F. Linton
, Sergio Fazio
Research output
:
Contribution to journal
›
Review article
›
peer-review
59
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cyclooxygenase-2 and atherosclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cyclooxygenase-2
100%
LDL Receptor Knockout Mice
57%
Cyclooxygenase-1 (COX-1)
42%
Macrophages
28%
Platelets
28%
Cyclooxygenase-2 Inhibitors
28%
Thromboxane A2 (TXA2)
28%
Fetal Liver Cells
28%
Prostacyclin
28%
Platelet Aggregation
14%
Vascular Tone
14%
Pharmacological Inhibitors
14%
Thrombosis
14%
Physiological Processes
14%
Vessel Wall
14%
Thrombotic
14%
Cyclooxygenase Inhibitors
14%
Non-selective
14%
Cardiovascular Events
14%
Platelet Activation
14%
Indomethacin
14%
Vasodilator
14%
Eicosanoids
14%
Western Diet
14%
Prospective Clinical Trial
14%
Cyclooxygenase-2 Expression
14%
Platelet Agonists
14%
Local Inflammatory Response
14%
Early Atherosclerosis
14%
Liver Cell Transplantation
14%
Rofecoxib
14%
Activated Monocytes
14%
Vasoconstrictor
14%
Monocytes/macrophages
14%
Controversial Issues
14%
Genetic Evidence
14%
Proatherogenic
14%
Aggregation Control
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 2
100%
Atherosclerosis
100%
Low Density Lipoprotein Receptor
50%
Cyclooxygenase 1
25%
COX-2 Inhibitor
25%
Prostacyclin
25%
Thromboxane A2
25%
Clinical Trial
12%
Inflammation
12%
Prostaglandin Synthase
12%
Thrombosis
12%
Knockout Mouse
12%
Prostaglandin Synthase Inhibitor
12%
Icosanoid
12%
Indometacin
12%
Rofecoxib
12%
Pathogenesis
12%